Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial.
Xiaoxi Yao, David R Rushlow, Jonathan W Inselman...
https://pubmed.ncbi.nlm.nih.gov/33958795/Actively Recruiting
Led by Peerbridge Health, Inc · Updated on 2026-06-01
2000
Participants Needed
8
Research Sites
N/A
Total Duration
Researchers are evaluating an investigational artificial intelligence AI software designed to estimate the severity of ejection fraction EF, which indicates how well the heart pumps blood. This prospective, multicenter, cluster-randomized controlled study compares EF severity categories determined by the AI software using continuous ECG waveform data to those measured by an FDA-cleared transthoracic echocardiogram TTE. The study aims to provide a low-burden, cost-effective alternative for EF monitoring in heart failure and related heart conditions, especially where traditional imaging access is limited. Participants will use the FDA-cleared Peerbridge COR4 ECG Wearable Monitor, a patch device worn during daily activities, to collect ECG data. During a 15-minute resting session while seated upright, 5-minute ECG segments will be recorded and analyzed by the AI software to estimate EF severity based on the American Society of Echocardiographys scale. The study includes two subprotocols one with 30 minutes of ECG recording including 15 minutes analyzed, and another allowing up to 7 days of device use with periodic sitting sessions. The EF severity from the AI software will be compared against results from echocardiography. Participants will be enrolled at multiple sites, providing paired data points consisting of simultaneous or near-simultaneous ECG recordings and echocardiograms. They will follow a standardized 15-minute seated session protocol using the wearable device, pressing an event button to mark the session start and end. Data collection includes medical histories, 12-lead ECGs, and device logs. The main outcome measures focus on agreement between the AI softwares EF severity categories and those from echocardiography over an average of 9 months. Safety and compliance will be monitored throughout the study period.
CONDITIONS
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
S
Sandeep Gulati, PhD
C
Chris Darland, MBA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Peerbridge Health, Inc
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telehealth)
Duration - Up to 7 days
Participants wear the Peerbridge Cor® ECG device to collect continuous ECG data used for ejection fraction severity assessment.
1 in-clinic setup visit or telehealth setup; ECG recording sessions up to 7 days
Duration - Same day as ECG recording or within 3 hours
Participants undergo transthoracic echocardiography (Echo) to provide a reference standard for ejection fraction severity.
1 visit (in-person) for Echo and simultaneous 12-lead ECG
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Xiaoxi Yao, David R Rushlow, Jonathan W Inselman...
https://pubmed.ncbi.nlm.nih.gov/33958795/Demilade Adedinsewo, Rickey E Carter, Zachi Attia...
https://pubmed.ncbi.nlm.nih.gov/32986471/Hung-Yi Chen, Chin-Sheng Lin, Wen-Hui Fang...
https://pubmed.ncbi.nlm.nih.gov/35330455/Wesley T O'Neal, Matylda Mazur, Alain G Bertoni...
https://pubmed.ncbi.nlm.nih.gov/28546456/Sona M Al Younis, Leontios J Hadjileontiadis, Ahsan H Khandoker...
https://pubmed.ncbi.nlm.nih.gov/38739639/Veer Sangha, Arash A Nargesi, Lovedeep S Dhingra...
https://pubmed.ncbi.nlm.nih.gov/37489538/Mohammad Alhamaydeh, Richard Gregg, Abdullah Ahmad...
https://pubmed.ncbi.nlm.nih.gov/32554161/Roberto M Lang, Luigi P Badano, Victor Mor-Avi...
https://pubmed.ncbi.nlm.nih.gov/25559473/Artemio García-Escobar, Silvio Vera-Vera, Alfonso Jurado-Román...
https://pubmed.ncbi.nlm.nih.gov/35904538/Gillian Murtagh, Ian R Dawkins, Ronan O'Connell...
https://pubmed.ncbi.nlm.nih.gov/22416086/Peerbridge Health, Inc
Lead Sponsor